Immunogenicity and protection of the Theileria parva CTL antigen Tp1, with or without a leader sequence, using HAd5/MVA prime-boost vaccination
Saved in:
Main Authors: | Svitek, Nicholas, Saya, R., Awino, Elias, Gilbert, S.C., Poole, Elizabeth J., Nene, Vishvanath M., Steinaa, Lucilla |
---|---|
Published: |
2016-07-07T07:52:27Z
|
Online Access: | https://hdl.handle.net/10568/75989 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Ad5/MVA antigen delivery systems
by: Svitek, Nicholas, et al.
Published: (2015-07-27T13:35:12Z) -
Discovery of novel CTL epitopes by peptide library screening of CTL lines from Theileria parva immune animals
by: Svitek, Nicholas, et al.
Published: (2016-07-07T07:54:31Z) -
Systematic determination of TCR-antigen and peptide-MHC binding kinetics among field variants of a Theileria parva polymorphic CTL epitope
by: Svitek, Nicholas, et al.
Published: (2022-01-17T14:52:15Z) -
BoLA-6*01301 and BoLA-6*01302, two allelic variants of the A18 haplotype, present the same epitope from the Tp1 antigen of Theileria parva
by: Svitek, Nicholas, et al.
Published: (2015-07-09T05:42:09Z) -
IL-12 DNA Displays efficient adjuvant effects improving immunogenicity of Ag85A in DNA prime/MVA boost immunizations
by: Morelli, María Paula, et al.
Published: (2020-09)